论文部分内容阅读
近日本刊获悉,由北京皇岛植物胶囊有限公司之全资子公司——秦皇岛药用胶囊有限公司和中国科学院海洋研究所共同研制的海藻多糖植物空心胶囊,即将大规模投放市场。该项目属于国家863课题、“十一五”重大科技成就,海藻多糖植物空心胶囊的主要成分是海藻多糖和植物膳食纤维素。我国自主研发的这种纯天然植物胶囊,有望逐步替代动物明胶胶囊,为药物换上更为安全的“纯天然外衣”。
Recently, this magazine was informed that by the Beijing Huangdao Plant Capsule Co., Ltd. a wholly owned subsidiary - Qinhuangdao Pharmaceutical Capsules Co., Ltd. and the Chinese Academy of Sciences Institute of Ocean jointly developed seaweed polysaccharide plant hollow capsules, is about to launch on a large scale. The project belongs to the national 863 project, “Eleventh Five-Year” major scientific and technological achievements, seaweed polysaccharide plant hollow capsules are the main components of seaweed polysaccharides and plant dietary fiber. China’s independent research and development of this pure natural plant capsules, is expected to gradually replace animal gelatin capsules for the drug to put more safe “pure natural coat ”.